This concise, action-oriented session equips pharmacists with practical strategies for managing type 2 diabetes in patients at risk for, or living with, CVD and CKD. Focusing on real-life patient scenarios, it highlights easy-to-implement interventions—from applying the ABCDES framework to selecting evidence-based therapies like SGLT2 inhibitors and GLP-1 receptor agonists. Attendees will leave with concrete steps to individualize pharmacotherapy, a holistic approach to cardiorenal risk reduction, and streamlining of medication adjustments, all while enhancing patient engagement and outcomes.

Sponsored by Novo Nordisk